Have a personal or library account? Click to login
Associations Between Metabolic Syndrome, Ulcerative Colitis, and Fecal sST2 and CXCL8 Levels: Unveiling New Inflammatory Pathways Cover

Associations Between Metabolic Syndrome, Ulcerative Colitis, and Fecal sST2 and CXCL8 Levels: Unveiling New Inflammatory Pathways

EABR. Experimental and Applied Biomedical Research
Volume 26 (2025): Issue 1 (March 2025)
By: Samir Vucelj,  Irfan Corovic,  Marina Jovanovic,  Andjela Petrovic,  Isidora Stanisavljevic,  Bojan Stojanovic,  Kemal Corovic,  Ivana Andrejevic,  Natasa Zdravkovic,  Milica Dimitrijevic Stojanovic,  Goran Balovic and  Bojana Stojanovic  
Open Access
|Jan 2024

Figures & Tables

Figure 1.

Levels of sST2 in ulcerative colitis (UC) patients, with and without co-existing metabolic syndrome (MetS). The graph illustrates both serum (A) and fecal (B) sST2 concentrations. Statistical significance between groups was determined using either the Student's t-test or the Mann-Whitney U test, as appropriate. Data are presented as mean ± standard error of the mean.
Levels of sST2 in ulcerative colitis (UC) patients, with and without co-existing metabolic syndrome (MetS). The graph illustrates both serum (A) and fecal (B) sST2 concentrations. Statistical significance between groups was determined using either the Student's t-test or the Mann-Whitney U test, as appropriate. Data are presented as mean ± standard error of the mean.

Figure 2.

Depicts the levels of CXCL8 in patients diagnosed with ulcerative colitis (UC), with and without co-existing metabolic syndrome (MetS). The serum (A) and fecal (B) CXCL8 concentrations are represented in the figure. For the determination of statistically significant differences, we employed either the Student's t-test or the Mann-Whitney U test, as per the data distribution. Data are articulated as mean ± standard error of the mean.
Depicts the levels of CXCL8 in patients diagnosed with ulcerative colitis (UC), with and without co-existing metabolic syndrome (MetS). The serum (A) and fecal (B) CXCL8 concentrations are represented in the figure. For the determination of statistically significant differences, we employed either the Student's t-test or the Mann-Whitney U test, as per the data distribution. Data are articulated as mean ± standard error of the mean.
DOI: https://doi.org/10.2478/sjecr-2023-0013 | Journal eISSN: 2956-2090 | Journal ISSN: 2956-0454
Journal RSS Feed
Language: English
Page range: 23 - 29
Submitted on: Jul 26, 2023
Accepted on: Dec 7, 2023
Published on: Jan 24, 2024
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Ulcerative Colitis,
Metabolic Syndrome,
sST2,
CXCL8,
Immune Response
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2024 Samir Vucelj, Irfan Corovic, Marina Jovanovic, Andjela Petrovic, Isidora Stanisavljevic, Bojan Stojanovic, Kemal Corovic, Ivana Andrejevic, Natasa Zdravkovic, Milica Dimitrijevic Stojanovic, Goran Balovic, Bojana Stojanovic, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 26 (2025): Issue 1 (March 2025)Next article